Related Experiment Videos
Folic acid supplementation with methotrexate therapy: what benefit if any?
Journal of the American Academy of Dermatology
|October 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis.
Alimentary pharmacology & therapeutics·2015
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years.
The British journal of dermatology·2012
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
The British journal of dermatology·2008
Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.
Dermatology (Basel, Switzerland)·2008
HPV-Associated Cutaneous Malignancy in Solid Organ Transplant Recipients: The Role of the Dermatologist in Management and Prevention: Part II.
Journal of the American Academy of Dermatology·2026
HPV-Associated Cutaneous Malignancies in Solid Organ Transplant Recipients: Identification and the Role of the Dermatologist: Part 1.
Journal of the American Academy of Dermatology·2026
RANDOMIZED CONTROLLED STUDY OF NEMOLIZUMAB IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ASSOCIATED PRURITUS: NIKAIA-1.
Journal of the American Academy of Dermatology·2026
Guidelines for diagnostic testing in adults with presumed atopic dermatitis refractory to treatment.
Journal of the American Academy of Dermatology·2026
Cardiometabolic Associations of Dermatological Treatments. Part II: Targeted and Biologic Therapies.
Journal of the American Academy of Dermatology·2026
A Flavonoid Malonyltransferase MnMaT1, Directly Regulated by MnATHB51, Leads to the Biosynthesis of Acylated Flavonol Glucosides in Morus notabilis.
Journal of agricultural and food chemistry·2026
Melandryoside attenuates steatohepatitis and fibrosis by restoring PPM1A-mediated SMAD signaling termination.
Frontiers in pharmacology·2026